Use of Ivermectin in Humans

  • Bruce M. Greene
  • Kenneth R. Brown
  • Hugh R. Taylor


Ivermectin (Campbell et al. 1983) has been extensively tested in human onchocerciasis, and is now considered the drug of choice. In a single yearly dose, it suppresses microfilariae in the skin and eyes, and in most infected persons prevents disease progression. It also shows considerable promise for treatment of lymphatic filariasis and strongyloidiasis.


Lymphatic Filariasis Ivermectin Treatment Bancroftian Filariasis Skin Snip Human Onchocerciasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Albiez EJ, Newland HS, White AT, Kaiser A, Greene BM, Taylor HR, Buttner DW (1988) Chemotherapy of onchocerciasis with high doses of diethylcarbama- zine or a single dose of ivermectin: microfilaria levels and side effects. Trop. Med. Parasit. 39:19–24.Google Scholar
  2. Awadzi K, Dadzie KY, Schulz-Key H, Gilles HM, Fulford AJ, Azia MA (1986) The chemotherapy of onchocerciasis XI. A double-blind comparative study of ivermectin, diethylcarbamazine, and placebo in human onchocerciasis in Northern Ghana. Ann. Trop. Med. Parasit. 80:433–442.PubMedGoogle Scholar
  3. Awadzi K, Kadzie KY, Schulz-Key H, Haddock DRW, Gilles HM, Aziz MA (1984) Ivermectin in onchocerciasis (letter). Lancet 2:2921.Google Scholar
  4. Awadzi K, Dadzie KY, Schulz-Key H, Haddock DRW, Gilles HM, Aziz MA (1985) The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis. Ann. Trop. Med. Parasit. 79:63–78.PubMedGoogle Scholar
  5. Aziz MA, Diallo S, Diop IM, Lariviere M, Porta M (1982a) Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 2:171–173.PubMedCrossRefGoogle Scholar
  6. Aziz MA, Diallo S, Lariviere M, Diop IM, Porta M, Gaxotte P (1982b) Ivermectin in onchocerciasis. Lancet 2:1456–1457.PubMedCrossRefGoogle Scholar
  7. Bird AC, El-Sheikh H, Anderson J, Fuglsang H (1980) Changes in visual function and in the posterior segment of the eye during treatment of onchocerciasis with diethylcarbamazine citrate. Brit. J. Ophthalmol. 64:191–200.CrossRefGoogle Scholar
  8. Campbell WC, Fisher MH, Stapley EO, Albers-Schonberg G, Jacob TA (1983) Ivermectin: a potent new antiparasitic agent. Science 221:823–828.PubMedCrossRefGoogle Scholar
  9. Coulaud JP, Lariviere M, Aziz MA, Gervais MC, Gaxotte P, Deluol AM, Cenac J (1984) Ivermectin in onchocerciasis. Lancet 2:526–527.PubMedCrossRefGoogle Scholar
  10. Coulaud JP, Lariviere M, Gervais MC, Gaxotte P, Aziz MA, Deluol AM, Cenac J (1983) Treatment of human onchocerciasis with ivermectin. Bull. Soc. Pathol. Exot. Filiales 76:681–688.PubMedGoogle Scholar
  11. Cupp EW, Bernardo MJ, Kiszewski AE, Collins RC, Taylor HR, Aziz MA, Greene BM (1986) The effects of ivermectin on transmission of Onchocerca volvulus. Science 231:740–742.PubMedCrossRefGoogle Scholar
  12. Dadzie KY, Bird AC, Awadzi K, Schulz-Key H, Gilles HM, Aziz MA (1987) Ocular findings is a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis. Brit. J. Ophthalmol. 71:78–85.CrossRefGoogle Scholar
  13. Diallo S, Aziz MA, Lariviere M, Diallo JS, Diop-Mar I, N’Dir O, Badiane S, Py D, Schulz-Key H, Gaxotte P, Victorius A (1986) A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis. Trans. Roy. Soc. Trop. Med. Hyg. 80:927–934.PubMedCrossRefGoogle Scholar
  14. Diallo S, Aziz MA, Ndir O, Badiane S, Bah IB, Gaye O. (1987) Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti. Lancet 1:1030.PubMedCrossRefGoogle Scholar
  15. Drummond RO (1985) Effectiveness of ivermectin for control of arthropod pests of livestock. Southwest. Entomol. (Suppl.) 7:34–42.Google Scholar
  16. Duke BO (1968) The effects of drugs on Onchocerca volvulus I. Methods of assessment, population dynamics of the parasite and the effects of diethylcar- bamazine. Bull. WHO 39:137–146.PubMedGoogle Scholar
  17. Editorial (1984) Ivermectin in onchocerciasis. Lancet 2:1021.Google Scholar
  18. Greene BM, Taylor HR, Cupp EW, Murphy RP, White AT, Aziz MA, Schulz-Key H, D’Anna SA, Newland HS, Goldschmidt LP, Auer C, Hanson AP, Freeman SV, Reber EW, Williams PN (1985) Comparison of ivermectin and diethylcar- bamazine in the treatment of onchocerciasis. New Engl. J. Med. 313:133–138.PubMedCrossRefGoogle Scholar
  19. Greene BM, White AT, Newland HS, Keyvan-Larijani E, Dukuly F, Gallin MY, Aziz MA, Williams PN, Taylor HR (1987) Single dose therapy with ivermectin for onchocerciasis. Trans. Assoc. Amer. Phys. C: 131–138.Google Scholar
  20. Hussein S, Bird A, Jones BR (1987) Ocular lesions seen in phase III trial of ivermectin therapy of onchocerciasis in Togo. Trop. Med. Parasit. 38:67.Google Scholar
  21. Kumaraswami V, Ottesen EA, Vijayasekaran MD, Uma Devi S, Sxaminathan M, Aziz MA, Sarma GR, Prabhakar R, Tripathy SP (1988) Ivermectin for the treatment of Wuchereria bancrofti filariasis. JAMA 259:3150–3153.PubMedCrossRefGoogle Scholar
  22. Lariviere M, Abelloos J, Aziz M, Beauvais B, Bamba M, Ferly-Therizol M, Basset D, Basset A, Derouin F, Sarfati C, Bosseboeuf C, Toure Y, Song D, Gaxotte P (1986) A double-blind study of ivermectin and placebo in onchocerciasis. Proceedings of the IXth International Congress of Infectious and Parasitic Diseases, Munich, p 548.Google Scholar
  23. Lariviere M, Aziz MA, Weimann D, Ginoux J, Gaxotte P, Vinotain P, Brauvae B, Derouin F, Schulz-Key H, Barret D, Sarfati C (1985) Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement. Lancet 2:174–177.PubMedCrossRefGoogle Scholar
  24. Lindley D (1987) Merck’s new drug free to WHO for river blindness programme. Nature 329:752.PubMedGoogle Scholar
  25. Mossinger J, Schulz-Key H, Helling G, Adjamgba A, Klager S (1987) Emergence of Onchocerca volvulus microfilariae from skin biopsies of patients treated with ivermectin. Trop. Med. Parasit. 38:69.Google Scholar
  26. Nalin D Aziz M, Neu D, Ruiz-Palacios G, Naquira C (1987) Efficacy of ivermectin (MK-933) against intestinal nematode parasites. Abstract A-101. Annual Meeting of the American Society for Microbiology, Atlanta, p 17.Google Scholar
  27. Newland HS, White AT, Greene BM, D’Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR (1988) The effect of single dose ivermectin therapy on human O. volvulus infection with onchocercal ocular involvement. Brit. J. Ophthalmol. 72:561–569.CrossRefGoogle Scholar
  28. Newland HS, White AT, Greene BM, Keyvan-Larijani E, Taylor HR (in press) The effect of repeated treatment with ivermectin in onchocerciasis. Report of Third General Assembly of the International Agency for Prevention of Blindness.Google Scholar
  29. Ottesen EA, Kumaraswami V, Vijayasekaran MA, Aziz R, Prabhakar R, Tripathy SP (1987) Ivermectin and diethylcarbamazine (DEC) in a blinded, placebo- controlled trial to treat Wuchereria bancrofti (Wb) filariasis. Proceedings of the 36th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Los Angeles, p 255.Google Scholar
  30. Prod’hon J, Lardeux P, Bain O, Hebrard G, Pπxľhom JM (1987) Ivermectine et modalites de la reduction de ľinfection des simulies. Ann. Parasitol. Hum. Comp. 68:590–598.Google Scholar
  31. Ranque P, Aziz M, Pichard E, Ginoux J, Cozette P, Rivaud C, Sacko A, Coulibaly S, Gaxotte P (1986) A double-blind study of ivermectin and placebo in onchocerciasis in Mali. Proceedings of the IXth International Congress of Infectious and Parasitic Diseases, Munich, p 140.Google Scholar
  32. Richard-Lenoble D, Kombila M, Rupp EA, Pappaylion ES, Gaxotte P, Njuiri C, Aziz MA (1988) Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am. J. Trop Med Hyg 39:480–483.PubMedGoogle Scholar
  33. Roux J, Cartel JL, Aziz MA (1987) A dose-ranging study of ivermectin for the treatment of microfilaremic filariasis due to Wuchereria bancrofti in French Polynesia. Abstract 395. 36th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Los Angeles.Google Scholar
  34. Schulz-Key H, Greene BM, Awadzi K, Lariviere M, Klager S, Dadzie Y, Aziz MA (1986) Efficacy of ivermectin on the reproductivity of female Onchocerca volvulus. Trop. Med. Parasit. 37:89.Google Scholar
  35. Schulz-Key H, Klager S, Awadzi K, Diallo S, Greene BM, Lariviere M, Aziz MA (1985) Treatment of human onchocerciasis: the efficacy of ivermectin on the parasite. Trop. Med. Parasit. 36:20.Google Scholar
  36. Taylor HR (1984) Recent developments in the treatment of onchocerciasis. Bull. WHO 509–515.Google Scholar
  37. Taylor HR, Murphy RP, Newland HS, White AT, D’Anna SA, Keyvan-Larijani E, Aziz MA, Cupp EW, Greene BM (1986) Comparison of the treatment of ocular onchocerciasis with ivermectin and diethylcarbamazine. Arch. Ophthalmol. 104:863–870.PubMedGoogle Scholar
  38. Taylor HR, Trpis M, Cupp EW, Brotman B, Newland HS, Soboslay PT, Greene BM (1988) Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees. Am. J. Trop. Med. Hyg 39:86–90.PubMedGoogle Scholar
  39. White AT, Newland HS, Taylor HR, Erttmann KD, Keyvan-Larijani E, Nara A, Aziz MA, D’Anna SA, Williams PN, Greene BM (1987) Controlled trial and dose-finding study of ivermectin for treatment of onchocerciasis. J. Infect. Dis. 156:463–470.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1989

Authors and Affiliations

  • Bruce M. Greene
    • 1
  • Kenneth R. Brown
    • 2
  • Hugh R. Taylor
    • 3
  1. 1.Division of Geographic MedicineSchool of Medicine, University of Alabama at BirminghamBirminghamUSA
  2. 2.Department of Clinical ResearchMerck Sharp & Dohme Research LaboratoriesWest PointUSA
  3. 3.Dana Center for Preventive OphthalmologyThe Wilmer Institute, The Johns Hopkins UniversityBaltimoreUSA

Personalised recommendations